Switch to:
St Jude Medical Inc (NYSE:STJ)
Research and Development
$701 Mil (TTM As of Mar. 2014)

This is the expense the company spent on research and development. St Jude Medical Inc's research and development for the three months ended in Mar. 2014 was $170 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2014 was $701 Mil.


Definition

This is the expense the company spent on research and development.

St Jude Medical Inc Research & Development for the trailing twelve months (TTM) ended in Mar. 2014 was 173 (Jun. 2013 ) + 172 (Sep. 2013 ) + 186 (Dec. 2013 ) + 170 (Mar. 2014 ) = $701 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

St Jude Medical Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Research & Development 282369431476532560643709676691

St Jude Medical Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
Research & Development 177175173170158160173172186170
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide